Modeling and Simulation - PK/PD Archives | 第 15 页，共 38 页 | Certara

Brochure

IVIVC Software – Achieving Regulatory, Formulation and Manufacturing Success

In vitro-in vivo correlation (IVIVC) is an important, predictive mathematical tool in drug development, used…

Certara2016 年 11 月 8 日

Press Release

Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan

PRINCETON, NJ – Oct. 13, 2016 – Certara, the leading provider of decision support technology…

Certara2016 年 10 月 13 日

Publication

Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models

Certara2016 年 10 月 5 日

Publication

A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion

Metritis is a frequent problem in postpartum dairy cows. Intrauterine therapy with the antimicrobial oxytetracycline…

Certara2016 年 10 月 1 日

Publication

Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains

Certara2016 年 10 月 1 日

Blog

Arming Adherence-based Drug Development with Pharmacometrics

The time is right to explore how sensor-enabled digital adherence monitoring systems can benefit patients,…

Certara2016 年 9 月 12 日

Brochure

Phoenix NLME，面向当今科学家的现代 PK/PD 建模软件

Phoenix NLME 是一款用户友好、易于学习的 PK/PD 建模软件。Built from the…

Certara2016 年 9 月 12 日

Brochure

罕见病和孤儿药开发

There are 7,000 rare diseases impacting 350 million patients worldwide, yet only 300 of these…

Certara2016 年 8 月 3 日

Publication

Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation

Certara2016 年 8 月 1 日

Publication

Prediction of Altered Bile Acid Disposition Due to Inhibition of Multiple Transporters: An Integrated Approach Using Sandwich-cultured Hepatocytes, Mechanistic Modeling, and Simulation

Certara2016 年 8 月 1 日

© 2025 Certara. 保留所有权力。 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software